Login / Signup

Adamgammadex in patients to reverse a moderate rocuronium-induced neuromuscular block.

Ying Ying JiangYu Jun ZhangZhao Qiong ZhuYi Dan HuangDa Chun ZhouJing Chen LiuChao Yu LiJin LiuBin LiuWen Sheng Zhang
Published in: British journal of clinical pharmacology (2022)
Adamgammadex was found to be effective for reversal of rocuronium-induced neuromuscular block, and it was safe and well tolerated in patients.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • high glucose
  • diabetic rats
  • oxidative stress
  • patient reported outcomes
  • patient reported